Canada markets closed

TRIB May 2024 2.500 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.00000.0000 (0.00%)
As of 10:40AM EDT. Market open.
Full screen
Previous Close2.0000
Open2.0000
Bid0.1000
Ask5.0000
Strike2.50
Expire Date2024-05-17
Day's Range2.0000 - 2.0000
Contract RangeN/A
Volume1
Open InterestN/A
  • GlobeNewswire

    Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

    DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence (“AI”) company PulseAI to enhance the Company’s recently acquired continuous glucose monitor (CGM) biosensor technology. Under this collaboration, Trinity Biotech will provide a pool of unique multi-p

  • GlobeNewswire

    Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

    DUBLIN, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received substantial additional orders for TrinScreen HIV, bringing total orders received to date for supply in 2024 to approximately $6 million. The Company has successfully scaled up production to meet the increased demand for its rapid HIV tests. A

  • GlobeNewswire

    Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

    DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the appointment of Avinash Kale as Continuous Glucose Monitor (CGM) Programme Director. His appointment is a critical step forward in advancing the Company’s recently acquired CGM technology and in driving its innovation and development to bring an advanced CGM s